DCM Shriram profit and loss

Latest FY26

Revenue: ₹14,264cr+12.0% on FY25
EBITDA: ₹1,497cr+12.6% on FY25
Net profit: ₹856cr+41.7% on FY25
EPS: ₹54.73+41.2% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	15,312	14,264	12,741	11,431	12,080	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	130	196	142	98.5	120
	15,442	14,460	12,883	11,530	12,199
	6,472	5,867	5,360	5,276	4,784
	1,196	1,086	943	845	890
	−38.7	45.9	−15.0	−316	0.0
	1,308	1,260	1,070	984	891
	165	176	153	87.6	52.8
	531	502	410	303	260
	4,862	4,508	4,053	3,651	3,908
	14,495	13,445	11,974	10,831	10,786
	1,513	1,497	1,330	991	1,606
	981	995	920	688	1,346
Profit
	947	1,016	909	699	1,413
	56.0	−23.4	0.0	0.0	0.0
	1,003	992	909	699	1,413
	90.2	194	162	198	257
	−468	−57.2	143	53.9	245
	−377	136	305	252	502
	2.4	0.0	0.0	0.0	0.0
	1,383	856	604	447	911
	1,380	856	604	447	911
	0.0	4.5	−5.5	−7.7	12.8
	1,383	860	599	439	924
	—	853	—	—	—
	2.3	2.5	—	—	—
Per share
	₹88.74	₹54.73	₹38.75	₹28.67	₹58.41
	₹88.44	₹54.73	₹38.75	₹28.67	₹58.41
Other comprehensive income — detail
	0.0	4.5	−5.5	—	—
	3.3	4.2	−7.0	−9.1	0.9
	5.3	5.3	−2.4	—	—
	—	—	—	−3.3	0.2
	1.6	5.3	−1.5	−2.5	18.6
	−0.5	−0.3	−0.6	—	—
	—	—	—	−0.6	6.6
	—	858	—	439	924
	—	2.6	—	0.0	0.0
Per share — as-filed variants
	₹88.74	₹54.73	₹38.75	₹28.67	₹58.41
	₹88.44	₹54.73	₹38.75	₹28.67	₹58.41
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	7,682	7,265	6,453	5,626	6,405
	50.2%	50.9%	50.6%	49.2%	53.0%
Adjusted (ex-exceptional items) — derived
	947	1,016	909	699	1,413
	56.0	−23.4	0.0	0.0	0.0
	1,327	876	604	447	911
	₹85.14	₹56.02	₹38.75	₹28.67	₹58.41

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DCMSHRIRAM₹960.10

DCM Shriram Ltd.

· Others

Annual Quarterly₹ CrorePeersGNFC TRIVENI TTKHLTCARE BALMLAWRIE GODREJIND 3MINDIAMcap ₹15,050 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	12,079.5	11,431.3	12,741.3	14,263.9	15,311.8
Other Income	119.7	98.5	142.1	196.3	130.4
Total Income	12,199.2	11,529.8	12,883.5	14,460.2	15,442.1
Expenses
+ Cost of Materials Consumed	4,784.1	5,276.3	5,360.4	5,866.9	6,472.1
+ Purchases of Stock-in-Trade	890.0	845.3	942.9	1,086.0	1,196.2
+ Changes in Inventories	0.0	-316.1	-15.0	45.9	-38.7
+ Employee Benefit Expense	890.6	984.3	1,070.0	1,260.2	1,307.7
+ Finance Costs	52.8	87.6	152.8	175.7	165.1
+ Depreciation & Amortisation	260.2	302.9	410.2	502.4	531.2
+ Other Expenses	3,908.3	3,650.8	4,052.8	4,507.6	4,861.7
Total Expenses	10,786.1	10,831.1	11,974.1	13,444.6	14,495.4
EBITDA	1,606.4	990.7	1,330.3	1,497.3	1,512.6
EBIT	1,346.3	687.8	920.1	995.0	981.5
Profit
PBT before Exceptional Items	1,413.1	698.7	909.4	1,015.7	946.8
+ Exceptional Items	0.0	0.0	0.0	-23.4	56.0
Pretax Income	1,413.1	698.7	909.4	992.3	1,002.8
+ Current Tax	257.1	197.7	162.1	193.5	90.2
+ Deferred Tax	245.2	53.9	143.1	-57.2	-467.6
Tax Expense	502.3	251.6	305.1	136.3	-377.4
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	2.4
Net Income	910.8	447.1	604.3	856.0	1,382.6
+ Net Income — Continuing Ops	910.8	447.1	604.3	856.0	1,380.2
+ Other Comprehensive Income	12.8	-7.7	-5.5	4.5	0.0
Total Comprehensive Income	923.6	439.4	598.7	860.5	1,382.6
Net Income to Common	—	—	—	853.4	—
Minority Interest	—	—	—	2.5	2.3
Per Share
Basic EPS	58.41	28.67	38.75	54.73	88.74
Diluted EPS	58.41	28.67	38.75	54.73	88.44
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-5.5	4.5	0.0
+ Items NOT to be Reclassified to P&L	0.9	-9.1	-7.0	4.2	3.3
+ Tax on Items NOT to be Reclassified	—	—	-2.4	5.3	5.3
+ Tax on Items NOT to be Reclassified — alt tag	0.2	-3.3	—	—	—
+ Items to be Reclassified to P&L	18.6	-2.5	-1.5	5.3	1.6
+ Tax on Items to be Reclassified	—	—	-0.6	-0.3	-0.5
+ Tax on Items to be Reclassified — alt tag	6.6	-0.6	—	—	—
Comprehensive Income — Owners of Parent	923.6	439.4	—	857.9	—
Comprehensive Income — Non-controlling Interests	0.0	0.0	—	2.6	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	58.41	28.67	38.75	54.73	88.74
Diluted EPS — Continuing Operations	58.41	28.67	38.75	54.73	88.44
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	6,405.4	5,625.8	6,453.1	7,265.1	7,682.1
Gross Margin %	53.03	49.21	50.65	50.93	50.17
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	1,413.1	698.7	909.4	1,015.7	946.8
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-23.4	56.0
Net Income Adj (tax-effected)	910.8	447.1	604.3	876.2	1,326.5
EPS Adj	58.41	28.67	38.75	56.02	85.14
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Filed Debt Equity	—	0.00	0.20	0.23	0.11
Filed Dscr	—	4.00	5.44	5.29	3.19
Filed Iscr	—	9.00	17.14	15.31	11.84
Paid Up Equity Capital	31.4	31.4	31.4	31.4	31.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.